Alzheimer's
Neurology·MeSH: Dementia
114 drugs in development·60 companies·1 clinical trial
Drug Pipeline by Phase
Approved(4)
Phase 3(19)
Phase 2(23)
| Drug | Company |
|---|---|
| AL002 | Alector, Inc. (ALEC) |
| AL101/GSK4527226 | Alector, Inc. (ALEC) |
| ANAVEX® 2-73 (blarcamesine) | ANAVEX LIFE SCIENCES CORP. (AVXL) |
| ANAVEX® 3-71 (AF710B) | ANAVEX LIFE SCIENCES CORP. (AVXL) |
| bepranemab | GT Biopharma, Inc. (GTBP) |
| bryostatin-1 | Neurotrope, Inc. (NTRP) |
| ct1812 | COGNITION THERAPEUTICS INC (CGTX) |
| iti-1284 | Intra-Cellular Therapies, Inc. (ITCI) |
| kds2010 | SCILEX HOLDING CO (SCLX) |
| mivelsiran | ALNYLAM PHARMACEUTICALS, INC. (ALNY) |
| mk-1167 | Neuphoria Therapeutics Inc. (NEUP) |
| MK-2214 | Merck & Co., Inc. (MRK) |
| ml-007c-ma | MapLight Therapeutics, Inc. (MPLT) |
| montelukast versafilm | INTELGENX TECHNOLOGIES CORP. (IGXT) |
| nivisnebart (formerly AL101/GSK4527226) | Alector, Inc. (ALEC) |
| NurOwn® | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) |
| RO7269162 | Crinetics Pharmaceuticals, Inc. (CRNX) |
| sabirnetug | Acumen Pharmaceuticals, Inc. (ABOS) |
| sabirnetug (ACU193) | Acumen Pharmaceuticals, Inc. (ABOS) |
| sar448851 | Sanofi (SNY) |
| ub-311 | Vaxxinity, Inc. (VAXX) |
| vhb937 | Novartis AG (NVS) |
| zervimesine (CT1812) | COGNITION THERAPEUTICS INC (CGTX) |
Phase 1(18)
Preclinical(41)
Unknown(2)
| Drug | Company |
|---|---|
| Medical formulations portfolio | Cannabis Bioscience International Holdings, Inc. (CBIH) |
| Xpro1595/INB03 | Xencor Inc (XNCR) |
N/A(1)
| Drug | Company |
|---|---|
| MK-6240 | Lantheus Holdings, Inc. (LNTH) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| abbv-1758 | AbbVie Inc. (ABBV) |
Phase 2/Phase 3(2)
Phase 4(3)
Compare drugs
Frequently asked questions
How many drugs are in development for Alzheimer's?
BioSniper tracks 114 drugs in development for Alzheimer's across 60 companies.
How many clinical trials target Alzheimer's?
There are 1 clinical trial targeting Alzheimer's tracked by BioSniper.
Analyze ELI LILLY & Co's Alzheimer's pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company